RU2021106290A - VETERINARY MEDICINE INTENDED FOR THE TREATMENT OF CATS WITH INFECTIOUS (VIRAL) PERITONITIS - Google Patents

VETERINARY MEDICINE INTENDED FOR THE TREATMENT OF CATS WITH INFECTIOUS (VIRAL) PERITONITIS Download PDF

Info

Publication number
RU2021106290A
RU2021106290A RU2021106290A RU2021106290A RU2021106290A RU 2021106290 A RU2021106290 A RU 2021106290A RU 2021106290 A RU2021106290 A RU 2021106290A RU 2021106290 A RU2021106290 A RU 2021106290A RU 2021106290 A RU2021106290 A RU 2021106290A
Authority
RU
Russia
Prior art keywords
cats
treatment
peritonitis
infectious
viral
Prior art date
Application number
RU2021106290A
Other languages
Russian (ru)
Inventor
Николай Андреевич Козлов
Original Assignee
Николай Андреевич Козлов
Filing date
Publication date
Application filed by Николай Андреевич Козлов filed Critical Николай Андреевич Козлов
Publication of RU2021106290A publication Critical patent/RU2021106290A/en

Links

Claims (2)

1. Фармацевтическая композиция для лечения кошек с заболеванием инфекционный перитонит, характеризующаяся тем, что содержит нуклеозидный аналог GS-441524 в концентрации 10 мг/мл, полиэтиленгликоль 400 - 65%, этиловый спирт 5%, соляную кислоту рН 4.0, воду для инъекций 30%.1. Pharmaceutical composition for the treatment of cats with infectious peritonitis, characterized in that it contains the nucleoside analogue GS-441524 at a concentration of 10 mg/ml, polyethylene glycol 400 - 65%, ethyl alcohol 5%, hydrochloric acid pH 4.0, water for injection 30% . 2. Фармацевтическая композиция для лечения кошек с заболеванием инфекционный перитонит, характеризующаяся тем, что содержит нуклеозидный аналог GS-441524 в концентрации 10 мг/мл, полиэтиленгликоль 400 - 60%, гидроксипропил циклодекстрин в концентрации 30 мг/мл, этиловый спирт 5%, соляную кислоту рН 4.0, воду для инъекций 35%.2. Pharmaceutical composition for the treatment of cats with infectious peritonitis, characterized in that it contains the nucleoside analogue GS-441524 at a concentration of 10 mg/ml, polyethylene glycol 400 - 60%, hydroxypropyl cyclodextrin at a concentration of 30 mg/ml, ethyl alcohol 5%, hydrochloric acid acid pH 4.0, water for injection 35%.
RU2021106290A 2021-03-11 VETERINARY MEDICINE INTENDED FOR THE TREATMENT OF CATS WITH INFECTIOUS (VIRAL) PERITONITIS RU2021106290A (en)

Publications (1)

Publication Number Publication Date
RU2021106290A true RU2021106290A (en) 2022-09-12

Family

ID=

Similar Documents

Publication Publication Date Title
ES2860526T3 (en) Preserved Etherified Cyclodextrin Derivatives Containing A Liquid Aqueous Pharmaceutical Composition
RU2470016C2 (en) Bipirazole derivative
CY1111159T1 (en) CONCENTRATED Methotrexate Solutions
JP2015527402A5 (en)
AR063150A1 (en) STABLE FORMULATIONS
BRPI0413756A (en) compound, methods for treating or preventing spasticity or a symptom of spasticity, gastro-oesophageal reflux disease, drug addiction, alcohol addiction or abuse, or nicotine abuse or addiction, and cough or emesis in a patient, and, pharmaceutical composition
UY26779A1 (en) PRODROGAS 3` DE 2 '-DESOXI-B-L-NUCLEÓSIDOS
HUT75684A (en) Parenteral solutions of diclofenac salts
BRPI0616536B8 (en) use of a hydroxybenzoic acid ester
RU2009123536A (en) Stable parenteral formulations, including benzodiazepine-based PCB inhibitors
GT200600263A (en) DOSAGE REGIME FOR PRASUGREL
JP2015510882A5 (en)
ES2403121T3 (en) Formulation of injectable paracetamol, stable, ready to use
CY1124236T1 (en) LEVONTOPA INJECTION SOLUTION
DK1502589T3 (en) Veterinary aqueous injectable suspensions containing florfenicol
RU2021106290A (en) VETERINARY MEDICINE INTENDED FOR THE TREATMENT OF CATS WITH INFECTIOUS (VIRAL) PERITONITIS
EA202193240A1 (en) STABILIZED COMPOSITIONS CONTAINING ANTI-ANGPTL3 ANTIBODIES
FI3672631T3 (en) Pharmaceutical compositions containing anti-beta amyloid antibodies
JP2016534062A5 (en)
EP4249069A3 (en) Aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
AR119805A1 (en) AQUEOUS PHARMACEUTICAL COMPOSITION OF PROLGOLIMAB ANTI-PD1 ANTIBODY AND ITS USE
US20030005889A1 (en) Method of improving hatchability of eggs
PA8682701A1 (en) FORMULATION OF PROLONGED RELEASE OF ACTIVE PRINCIPLES OF MEDICINES
MD3121F1 (en) Method of viral hepatitis B prophylaxis
ES2369296T3 (en) CONCENTRATED LIQUID COMPOSITION OF THYROID HORMONE.